Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kent Hutchison to Smoking Cessation

This is a "connection" page, showing publications Kent Hutchison has written about Smoking Cessation.

 
Connection Strength
 
 
 
1.077
 
  1. Littlewood RA, Claus ED, Wilcox CE, Mickey J, Arenella PB, Bryan AD, Hutchison KE. Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo. Psychopharmacology (Berl). 2017 Dec; 234(23-24):3417-3429.
    View in: PubMed
    Score: 0.421
  2. Ray LA, Miranda R, Kahler CW, Leventhal AM, Monti PM, Swift R, Hutchison KE. Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study. Psychopharmacology (Berl). 2007 Sep; 193(4):449-56.
    View in: PubMed
    Score: 0.206
  3. Bidwell LC, Karoly HC, Hutchison KE, Bryan AD. ADHD symptoms impact smoking outcomes and withdrawal in response to Varenicline treatment for smoking cessation. Drug Alcohol Depend. 2017 10 01; 179:18-24.
    View in: PubMed
    Score: 0.104
  4. Wilcox CE, Claus ED, Calhoun VD, Rachakonda S, Littlewood RA, Mickey J, Arenella PB, Goodreau N, Hutchison KE. Default mode network deactivation to smoking cue relative to food cue predicts treatment outcome in nicotine use disorder. Addict Biol. 2018 01; 23(1):412-424.
    View in: PubMed
    Score: 0.101
  5. Myers US, Hutchison KE, Filbey FM. Large variability in smokers obscure the G x E effects on tobacco dependence. Psychiatry Res. 2010 May 30; 177(3):369-70.
    View in: PubMed
    Score: 0.063
  6. Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, Stitzel J, Bryan A, McGeary J, Haughey HM. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry. 2007 Sep; 64(9):1078-86.
    View in: PubMed
    Score: 0.053
  7. Helstrom A, Hutchison K, Bryan A. Motivational enhancement therapy for high-risk adolescent smokers. Addict Behav. 2007 Oct; 32(10):2404-10.
    View in: PubMed
    Score: 0.051
  8. David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM, Day A, Stumpff J, Hutchison K, Murphy M, Johnstone E, Griffiths SE, Walton RT. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res. 2003 Dec; 5(6):935-42.
    View in: PubMed
    Score: 0.041
  9. Hutchison KE, Stevens VM, Collins FL. Cigarette smoking and the intention to quit among pregnant smokers. J Behav Med. 1996 Jun; 19(3):307-16.
    View in: PubMed
    Score: 0.024
  10. Rohsenow DJ, Tidey JW, Miranda R, McGeary JE, Swift RM, Hutchison KE, Sirota AD, Monti PM. Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers. Exp Clin Psychopharmacol. 2008 Jun; 16(3):215-22.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)